Entero Healthcare Solutions Limited (NSE: ENTERO) and Health X Platform Limited (Sastasundar Ventures Ltd) (NSE: HEALTHX) are both listed in the Pharmaceutical Product Distribution industry. Entero Healthcare Solutions has a market capitalisation of ₹6,846 Cr and Health X Platform ₹913 Cr, as of 9 Nov 2026. Their P/E ratios are 59.5 and 775.7 respectively. Return on equity is 8.28% for Entero Healthcare Solutions and -0.18% for Health X Platform. Over one year, Entero Healthcare Solutions's share price is up 89.2% and Health X Platform's is down 6.9%.
| Metric | Entero Healthcare Solutions | Health X Platform |
|---|---|---|
| NSE Symbol | ENTERO | HEALTHX |
| BSE Code | 544122 | 533259 |
| Share Price | ₹2,089.00 | ₹274.70 |
| Market Cap | ₹6,846 Cr | ₹913 Cr |
| P/E Ratio | 59.5 | 775.7 |
| Return on Equity | 8.28% | -0.18% |
| Return on Assets | 4.41% | -0.07% |
| Dividend Yield | — | 0.00% |
| Beta (1Y) | 0.14 | 0.23 |
| 1-Year Price Change | +89.2% | -6.9% |
| 3-Month Price Change | +58.8% | -9.3% |
| 52-Week Range | ₹944.00 – ₹2,137.60 | ₹252.50 – ₹363.00 |
| Latest Quarter | Q2 FY27 | Q1 FY27 |
| Quarterly Revenue | ₹2,087 Cr | ₹447 Cr |
| Quarterly Net Profit | ₹61 Cr | ₹2 Cr |
| Net Margin | 2.9% | 0.4% |
| EPS (Basic, Quarter) | ₹10.47 | ₹0.80 |
| Results Basis | consolidated | consolidated |
| Headquarters | Mumbai, Maharashtra | Kolkata, West Bengal |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics. It also provides private label products under the Entero Surgicals private label…
Health X Platform Limited operates a digital network of healthcare and portfolio management services in India. The company operates through the Financial Services and Healthcare Network segments. It is involved in the financing of loans; investment in shares and securities; and activities for pathology and marketing of healthcare and OTC products through e-commerce portal. The company also provides financial consultancy, professional fees, wealth management, financial planning, distribution, and related services, as well as diagnostic services, including pathological/radiological investigation…
Entero Healthcare Solutions has a market capitalisation of ₹6,846 Cr, against ₹913 Cr for Health X Platform as of 9 Nov 2026, about 7.5 times the size by market cap.
Entero Healthcare Solutions has a P/E of 59.5 and Health X Platform a P/E of 775.7 as of 9 Nov 2026.
Entero Healthcare Solutions has a return on equity of 8.28% and Health X Platform -0.18%.
Entero Healthcare Solutions's share price is up 89.2% over one year and Health X Platform's is down 6.9%.
Entero Healthcare Solutions reported revenue of ₹2,087 Cr and net profit of ₹61 Cr for Q2 FY27. Health X Platform reported revenue of ₹447 Cr and net profit of ₹2 Cr for Q1 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Health Care Providers and Services > Health Care Distributors > Pharmaceutical Product Distribution on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.